Statins and hemoperfusion improve 28-day survival in septic shock patients

• Nakamura Tsukasa,
• Sato Eiichi,
• Fujiwara Nobuharu,
• Kawagoe Yasuhiro,
• Maeda Sayaka,
• Inoue Hiroyoshi,
• Yamagishi Sho-ichi

Affiliations

Nakamura Tsukasa

Division of Nephrology, Department of Internal Medicine, Shinmatsudo Central General Hospital, Matsudo, 270-0034, Japan

Sato Eiichi

Division of Nephrology, Department of Internal Medicine, Shinmatsudo Central General Hospital, Matsudo, 270-0034, Japan

Fujiwara Nobuharu

Division of Nephrology, Department of Internal Medicine, Shinmatsudo Central General Hospital, Matsudo, 270-0034, Japan

Kawagoe Yasuhiro

Division of Nephrology, Department of Internal Medicine, Shinmatsudo Central General Hospital, Matsudo, 270-0034, Japan

Maeda Sayaka

Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume, 830-0011, Japan

Inoue Hiroyoshi

Department of Chemistry, Keio University School of Medicine, Yokohama, 223-8521, Japan

Yamagishi Sho-ichi

Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications, Kurume University School of Medicine, Kurume, 830-0011, Japan